4.6 Article

The Relationship between Glaucoma Medication Adherence, Eye Drop Technique, and Visual Field Defect Severity

期刊

OPHTHALMOLOGY
卷 118, 期 12, 页码 2398-2402

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2011.05.013

关键词

-

资金

  1. Alcon Research, Ltd., Forth Worth, Texas
  2. National Eye Institute, National Institutes of Health, Bethesda, Maryland [EY018400]
  3. National Center of Research Resources, National Institutes of Health [UL 1RR02574 7]

向作者/读者索取更多资源

Objective: The purpose of the study was to examine (1) how patient adherence and eye drop technique were associated with visual field defect severity and (2) how general glaucoma adherence self-efficacy and eye drop technique self-efficacy were related to visual field defect severity. Design: Cross-sectional study conducted at a single private practice site. Participants: Patients using eye drops for their glaucoma. Methods: Subject adherence to glaucoma medications through Medication Events Monitoring System (MEMS) devices were measured, and eye drop instillation technique was assessed by video recording. General glaucoma medication adherence self-efficacy was measured using a 10-item scale, and eye drop technique self-efficacy was measured using a 6-item scale. Multivariate logistic regression was used to analyze the data. Main Outcome Measures: Visual field defect severity. Results: Patients who were less than 80% adherent according to the MEMS devices were significantly more likely to have worse defect severity. Patients with lower scores on the general glaucoma medication adherence self-efficacy scale also were significantly more likely to have worse defect severity. Eye drop technique and eye drop technique self-efficacy were not related significantly to visual field defect severity. Conclusions: Eye care providers need to assess patient adherence and to work with those patients with poor adherence to find ways to improve their ability and self-efficacy in using their glaucoma medications. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references. Ophthalmology 2011; 118: 2398-2402 (C) 2011 by the American Academy of Ophthalmology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据